Marengo Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Marengo Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts. It pursues immunotherapies that mobilize the body's immune system to attack cancer, with an aim for rapid, effective, and durable anti-tumor responses. The company emphasizes selectively boosting T cells to drive potent tumor activity and to support long-term immunity against cancer. 

It operates within the biotechnology research sector, with a focus on precision immunotherapy for oncology and related inflammatory and immunology indications. As a smaller enterprise, it engages with the scientific community through conferences and data disclosures. In 2026, Marengo announced the IPN01203/STAR0501 STAR program at AACR and reported early Phase 2 results for invikafusp alfa in combination with TRODELVY.

Sign up for free to view info

Company overview Employee directory